205 related articles for article (PubMed ID: 21550375)
1. Formalin-inactivated vaccine provokes cross-protective immunity in a mouse model of human enterovirus 71 infection.
Bek EJ; Hussain KM; Phuektes P; Kok CC; Gao Q; Cai F; Gao Z; McMinn PC
Vaccine; 2011 Jun; 29(29-30):4829-38. PubMed ID: 21550375
[TBL] [Abstract][Full Text] [Related]
2. Formaldehyde-inactivated human enterovirus 71 vaccine is compatible for co-immunization with a commercial pentavalent vaccine.
Chen CW; Lee YP; Wang YF; Yu CK
Vaccine; 2011 Mar; 29(15):2772-6. PubMed ID: 21315698
[TBL] [Abstract][Full Text] [Related]
3. Immunoprotection elicited by an enterovirus type 71 experimental inactivated vaccine in mice and rhesus monkeys.
Dong C; Liu L; Zhao H; Wang J; Liao Y; Zhang X; Na R; Liang Y; Wang L; Li Q
Vaccine; 2011 Aug; 29(37):6269-75. PubMed ID: 21722686
[TBL] [Abstract][Full Text] [Related]
4. Immunization with virus-like particles of enterovirus 71 elicits potent immune responses and protects mice against lethal challenge.
Chung YC; Ho MS; Wu JC; Chen WJ; Huang JH; Chou ST; Hu YC
Vaccine; 2008 Mar; 26(15):1855-62. PubMed ID: 18329759
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of Coxsackievirus A5 Vaccine Candidates in an Actively Immunized Mouse Model.
Jin WP; Lu J; Zhang XY; Wu J; Wei ZN; Mai JY; Qian SS; Yu YT; Meng SL; Wang ZJ; Shen S
J Virol; 2021 Feb; 95(6):. PubMed ID: 33408178
[TBL] [Abstract][Full Text] [Related]
6. Combined peptides of human enterovirus 71 protect against virus infection in mice.
Liu JN; Wang W; Duo JY; Hao Y; Ma CM; Li WB; Lin SZ; Gao XZ; Liu XL; Xu YF; Xu WB; Qin C; Zhang LF
Vaccine; 2010 Oct; 28(46):7444-51. PubMed ID: 20831911
[TBL] [Abstract][Full Text] [Related]
7. Prospect and challenges for the development of multivalent vaccines against hand, foot and mouth diseases.
Liu CC; Chow YH; Chong P; Klein M
Vaccine; 2014 Oct; 32(47):6177-82. PubMed ID: 25218294
[TBL] [Abstract][Full Text] [Related]
8. Establishment of an animal challenge model as a potency assay for an inactivated Enterovirus Type 71 vaccine.
Wang KT; Lin SJ; Wang HC; Chen PC; Lin JJ; Chiang JR; Chang CL; Shih DY; Lo CF; Wang DY
Biologicals; 2016 Jul; 44(4):183-190. PubMed ID: 27068365
[TBL] [Abstract][Full Text] [Related]
9. Protective effect of enterovirus‑71 (EV71) virus‑like particle vaccine against lethal EV71 infection in a neonatal mouse model.
Cao L; Mao F; Pang Z; Yi Y; Qiu F; Tian R; Meng Q; Jia Z; Bi S
Mol Med Rep; 2015 Aug; 12(2):2473-80. PubMed ID: 25936344
[TBL] [Abstract][Full Text] [Related]
10. Comparison of single, homologous prime-boost and heterologous prime-boost immunization strategies against H5N1 influenza virus in a mouse challenge model.
Sabarth N; Howard MK; Savidis-Dacho H; van Maurik A; Barrett PN; Kistner O
Vaccine; 2010 Jan; 28(3):650-6. PubMed ID: 19896446
[TBL] [Abstract][Full Text] [Related]
11. A virus-like particle based bivalent vaccine confers dual protection against enterovirus 71 and coxsackievirus A16 infections in mice.
Ku Z; Liu Q; Ye X; Cai Y; Wang X; Shi J; Li D; Jin X; An W; Huang Z
Vaccine; 2014 Jul; 32(34):4296-303. PubMed ID: 24950363
[TBL] [Abstract][Full Text] [Related]
12. Broad protection with an inactivated vaccine against primary-isolated lethal enterovirus 71 infection in newborn mice.
Chang J; Li J; Liu X; Liu G; Yang J; Wei W; Zhang W; Yu XF
BMC Microbiol; 2015 Jul; 15():139. PubMed ID: 26169371
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of an inactivated Ross River virus vaccine in active and passive mouse immunization models and establishment of a correlate of protection.
Holzer GW; Coulibaly S; Aichinger G; Savidis-Dacho H; Mayrhofer J; Brunner S; Schmid K; Kistner O; Aaskov JG; Falkner FG; Ehrlich H; Barrett PN; Kreil TR
Vaccine; 2011 May; 29(24):4132-41. PubMed ID: 21477673
[TBL] [Abstract][Full Text] [Related]
14. Induction of protective immune responses against EV71 in mice by baculovirus encoding a novel expression cassette for capsid protein VP1.
Premanand B; Kiener TK; Meng T; Tan YR; Jia Q; Chow VT; Kwang J
Antiviral Res; 2012 Sep; 95(3):311-5. PubMed ID: 22691220
[TBL] [Abstract][Full Text] [Related]
15. A protective effect of epidermal powder immunization in a mouse model of equine herpesvirus-1 infection.
Kondo T; McGregor M; Chu Q; Chen D; Horimoto T; Kawaoka Y
Virology; 2004 Jan; 318(1):414-9. PubMed ID: 14972566
[TBL] [Abstract][Full Text] [Related]
16. Immunity to avirulent enterovirus 71 and coxsackie A16 virus protects against enterovirus 71 infection in mice.
Wu TC; Wang YF; Lee YP; Wang JR; Liu CC; Wang SM; Lei HY; Su IJ; Yu CK
J Virol; 2007 Oct; 81(19):10310-5. PubMed ID: 17626076
[TBL] [Abstract][Full Text] [Related]
17. Protective Efficacies of Formaldehyde-Inactivated Whole-Virus Vaccine and Antivirals in a Murine Model of Coxsackievirus A10 Infection.
Zhang Z; Dong Z; Li J; Carr MJ; Zhuang D; Wang J; Zhang Y; Ding S; Tong Y; Li D; Shi W
J Virol; 2017 Jul; 91(13):. PubMed ID: 28424287
[TBL] [Abstract][Full Text] [Related]
18. Enhanced neutralizing antibody response induced by inactivated enterovirus 71 in cynomolgus monkeys.
In HJ; Lim H; Lee JA; Lee SR; Jin YB; Jeong KJ; Hyeon JY; Yoo JS; Lee JW; Choi YK; Lee SW
PLoS One; 2018; 13(10):e0202552. PubMed ID: 30278051
[TBL] [Abstract][Full Text] [Related]
19. A Neonatal Murine Model of Coxsackievirus A6 Infection for Evaluation of Antiviral and Vaccine Efficacy.
Zhang Z; Dong Z; Wei Q; Carr MJ; Li J; Ding S; Tong Y; Li D; Shi W
J Virol; 2017 May; 91(9):. PubMed ID: 28250116
[TBL] [Abstract][Full Text] [Related]
20. VP1 of Enterovirus 71 Protects Mice Against Enterovirus 71 and Coxsackievirus B3 in Lethal Challenge Experiment.
Chen FH; Liu X; Fang HL; Nan N; Li Z; Ning NZ; Luo DY; Li T; Wang H
Front Immunol; 2019; 10():2564. PubMed ID: 31787970
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]